Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Option Grant to Recently Appointed CFO

19 May 2016 07:00

RNS Number : 6574Y
Plant Impact PLC
19 May 2016
 

For Immediate Release 19 May 2016

Plant Impact plc

 

Option Grant to Recently Appointed Chief Financial Officer

 

 

Plant Impact plc (AIM: PIM) ("Company" or the "Group"), an agricultural bioscience company that develops and markets crop enhancement and speciality nutrition products, announces that on 18 May 2016, the Company granted an Option ("VCP-Option") over 2,400,000 ordinary shares in the Company to Richard Amos, following his appointment as Chief Financial Officer and Executive Director on 10 May 2016. The extent to which the VCP-Option will actually vest and may be exercised by Mr Amos will be determined by the level of achievement of certain performance conditions, which are set out below ("Performance Conditions") and within the scope and terms of the "Value Creation Plan" which was approved by the Company's shareholders under Resolution 7 at the 20 November 2014 Annual General Meeting ("2014 AGM").

Consistent with the approval from shareholders via Resolution 7 at the 2014 AGM, the actual vesting of the VCP-Option will be subject to the achievement of the Performance Conditions designed to ensure that the VCP-Option does not vest unless there has been significant growth in the Company's share price ("Share Price") as well as significant growth in the Company's gross profit ("Gross Profit"). 

The VCP-Option issued to Mr Amos is over a maximum of 2,400,000 Shares and will vest on a date which is the later of: (1) a pre-determined contractual vesting date ("Vesting Date"), being three or more years from 18 May 2016; (2) the date on which the Share Price achieves a certain level ("Share Price Hurdle"); and (3) the date on which the Gross Profit, per the Group's most recently published audited annual accounts, exceeds certain thresholds. 

The Share Price at close yesterday was 55.0 pence and the average closing price over the previous 12 months was 56.5 pence.  The Company's most recently published Gross Profit was £3.5 million for the year to 31 July 2015.

The earliest Vesting Dates, Share Price Hurdles and Gross Profit levels which determine the potential vesting of Mr Amos's VCP-Option are set out in the following table:

Number of Shares subject to the VCP-Option (each a "Tranche")

Earliest Vesting Date

Share Price Hurdle

Gross Profit Threshold

480,000

18 May 2019

at least 70 pence

£4 million

480,000

18 May 2019

at least 90 pence

£8 million

480,000

18 May 2019

at least 110 pence

£8 million

480,000

18 May 2019

at least 130 pence

£12 million

480,000

18 May 2019

at least 150 pence

£12 million

 

However, notwithstanding the vesting of the VCP-Option, it may not generally be exercised until the expiry of the period of two years following the date of vesting, and if at the expiry of that two year period, the Share Price has declined more than 30% below the Share Price Hurdle which triggered the vesting of a particular Tranche of the VCP-Option, vesting of that Tranche shall be delayed until such time as the Share Price again achieves that Share Price Hurdle for at least 20 consecutive dealing days.

In no circumstances will a VCP-Option vest later than ten years from the date of grant.

It has been agreed with Mr Amos that in the event that he leaves the Company as a good leaver (broadly, any circumstances other than voluntary resignation or dismissal for cause), any Tranche of his VCP-Option will be permitted to vest and/or to be exercised to the extent that the relevant Share Price Hurdle and Gross Profit performance condition applicable to that Tranche as referred to in the table above have actually been achieved at the date of leaving.

 

For further information, contact:

Plant Impact

David Jones, Chairman Tel: +44 (0) 1582 465 540

John Brubaker, Chief Executive www.plantimpact.com

 

Peel Hunt - Nominated Advisor and Broker

Dan Webster Tel: +44 (0) 207 418 8900

Adrian Trimmings

George Sellar

 

Buchanan

Charles Ryland Tel: +44 (0) 207 466 5000

Sophie Cowles

Jane Glover

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFREFITLIR
Date   Source Headline
31st May 20118:30 amRNSTotal Voting Rights
24th May 20117:05 amRNS£2.05 million cash subscription by Arysta
24th May 20117:00 amRNSTrading update
6th Apr 20117:00 amRNSRule 17 disclosure
30th Mar 20118:30 amRNSHolding(s) in Company
11th Mar 20117:00 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSAppointment of new Chairman
30th Dec 20107:00 amRNSDirector/PDMR Shareholding
16th Dec 20109:50 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSHalf Yearly Report
24th Nov 201012:00 pmRNSHolding(s) in Company
18th Nov 20107:00 amRNSGrant of product registrations in Brazil
17th Nov 20107:00 amRNSDistribution and evaluation agreement
19th Oct 201010:30 amRNSHolding(s) in Company
23rd Sep 20107:00 amRNSEvaluation, Development and Distribution Agreement
26th Aug 201011:05 amRNSResult of AGM
25th Aug 20107:00 amRNSField Trials with Syngenta
12th Aug 20107:00 amRNSUpdated trial results
9th Aug 20107:00 amRNSGrant of Awards under LTIP and Share Options
5th Aug 20105:00 pmRNSPosting Annual Report and Accounts and AGM Notice
8th Jul 20102:20 pmRNSAppointment
14th Jun 20107:00 amRNSFinal Results
2nd Jun 20107:00 amRNSDistribution Agreement
29th Apr 20107:00 amRNSNotice of preliminary results and trading update
28th Apr 20107:00 amRNSField trial results
31st Mar 20103:30 pmRNSTotal Voting Rights
29th Mar 20102:46 pmRNSHolding(s) in Company
29th Mar 20102:45 pmRNSHolding(s) in Company
29th Mar 20102:30 pmRNSHolding(s) in Company
12th Mar 201011:15 amRNSResult of General Meeting
25th Feb 20107:00 amRNSIssue of Equity
8th Feb 20107:00 amRNSArysta agreement
3rd Feb 20107:00 amRNSPiNT study results
18th Jan 20107:00 amRNSFinalist at 2010 Grower of the Year Awards
6th Jan 20103:15 pmRNSDirectorate Change
6th Jan 201012:40 pmRNSChange of Adviser
7th Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200911:31 amRNSFurther Field Trial Results
22nd Oct 20097:00 amRNSAward of EU research grant
28th Sep 20097:00 amRNSTrading Statement
10th Sep 200910:36 amRNSHolding(s) in Company
10th Sep 200910:32 amRNSHolding(s) in Company
7th Sep 20098:31 amRNSNew Scientific Advisory Board Announcement
13th Aug 20098:41 amRNSSuccessful Application to Join Committee
6th Aug 20093:58 pmRNSGrant of Options
3rd Aug 20095:15 pmRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
31st Jul 200912:00 pmRNSTotal Voting Rights
30th Jul 200910:20 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.